Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Sources point to a single instance in which experimental therapy retatrutide was provided for ‘compassionate use’
By Lizzy Lawrence
June 23, 2026
FDA Reporter
WASHINGTON — Millions of Americans with obesity...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.